| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | -44.4% | -82.8% |
| Cost of Revenue | $0 | — | -100.0% |
| R&D Expense | $3.5M | -0.0% | -21.4% |
| SG&A Expense | $2.1M | -9.5% | -37.0% |
| Operating Income | -$5.6M | +3.7% | +27.7% |
| Interest Expense | $649K | -4.4% | -36.5% |
| Pre-tax Income | -$8.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.9M | +8.8% | -45.9% |
| Accounts Receivable | $0 | — | — |
| Inventory | $61K | -22.8% | -52.3% |
| Current Assets | $12.7M | +5.7% | -35.7% |
| Total Assets | $22.3M | +0.8% | -29.3% |
| Current Liabilities | $8.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.7M | — | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$11K | — | — |
| Financing Cash Flow | $9.4M | — | — |
| Free Cash Flow | -$13.8M | — | — |
| -9.9% |
| Income Tax | $0 | — | — |
| Net Income | -$8.8M | -18.3% | -9.9% |
| EPS (Basic) | -$0.85 | -9.0% | +30.3% |
| +9.7% |
| -65.1% |
| Long-term Debt | $17.9M | +8.6% | — |
| Total Liabilities | $34.7M | +13.0% | -2.9% |
| Stockholders' Equity | -$12.4M | -44.5% | -199.6% |